Retinal vasculitis associated with asymptomatic gardnerella vaginalis infection: A new clinical entity

Ocular Immunology and Inflammation

Volumn 17, Issue 1, 2009, Pages 36-40

  Neri, Piergiorgio ^a   Salvolini, Simone ^b   Giovannini, Alfonso ^b   Mariotti, Cesare ^b  

^a OSPEDALI RIUNITI   (Italy)

^b NONE

Author keywords

Ampicillin; Gardnerella vaginalis; Immunology; Infection; Retinal vasculitis

Indexed keywords

AMPICILLIN; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; HUMAN; RETINA VASCULITIS; SYMPTOM; VISUAL IMPAIRMENT;

ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; EYE INFECTIONS, BACTERIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; GARDNERELLA VAGINALIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETINAL VASCULITIS; VAGINOSIS, BACTERIAL;

EID: 67651227064     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802491876     Document Type: Article

References (16)

1. Duke-Elder S. Disease of the retina. In: System of Ophthalmology. London: Henry Kimpton; 1967;218-236.
2. AyliffW. Retinal vasculitis. In: Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002;822-843.
3. Herbort CP, Cimino L, Abu El Asrar A. Ocular vasculitis: a mul-tidisciplinary approach. Curr Opin Rheumatol. 2005;17:25-33.
4. Yasuhara T, Tada R, Nakano Y, et al. The presence of Propionibacterium spp. in the vitreous fluid of uveitis patients with sarcoidosis. Acta Ophthalmol Scand. 2005;83:364-369.
5. Mumcu G, Inanc N, Yavuz S, et al. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease. Clin Exp Rheumatol. 2007; 25(4 Suppl 45):S27-S33.
6. Kozireva SV, Zestkova JV, Mikazane HJ, et al. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Rheumatol. 2008 May 15 [Epub ahead of print].
7. Rosenbaum JT, Rosenzweig HL, Smith JR, et al. Uveitis secondary to bacterial products. Ophthalmic Res. 2008;40:165-168.
8. George T, Walton RC, Whitcup SM, et al. Primary retinal vasculitis: Systemic associations and diagnostic evaluation. Ophthalmology. 1996; 103:384-389.
9. Abu El-Asrar A, Tabbara K. Retinal vasculitis. Curr Opin Ophthalmol. 1997;8:68-79.
10. Au A, O'Day J. Review of severe vaso-occlusive retinopa-thy in systemic lupus erythematosus and the antiphos-pholipid syndrome: associations, visual outcome, complications and treatment. Clin Exp Ophthalmol. 2004;32:87-100.
11. Read RW. Uveitis: advances in understanding of pathogenesis and treatment. Curr Rheumatol Rep. 2006; 8:260-266.
12. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512-1523.
13. Perez VL, Chavala SH, Ahmed M, et al. Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol. 2004; 49:399-418.
14. Bartu V, Havelkova M, Kopecka E. QuantiFERON-TB Gold in the diagnosis of active tuberculosis. J Int Med Res. 2008; 36:434-437.
15. Dumonde DC, Kasp-Grochowska E, Graham E, et al. Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet. 1982;2:787-792.
16. Wakefield D, Easter J, Penny R. Immunological abnormalities in patients with untreated retinal vasculitis. Br J Ophthalmol. 1986; 70:260-265.